This study is checking if one dose of a drug called RE104 can help reduce symptoms of postpartum depression (PPD) in new moms. PPD is a kind of sadness that can happen after having a baby. To join, you must be within 15 months of having your baby and have stopped breastfeeding. You shouldn't be on other depression medications, unless it's a stable treatment you have been on for a month. Also, you can't be taking certain drugs or have serious mental health issues like bipolar disorder or schizophrenia.
- Time Commitment: The study involves a single dose, but you'll need to be screened and tested.
- Eligibility: You should not have severe mental health conditions or be at risk of harming yourself.
- Benefits/Risks: This research might help reduce depression symptoms. There are no specific risks mentioned, but as with any study, there might be some.
How understandable was the trial content above?
Hard to understand
Easy to understand